GBDC Stock +24.76% Since The Golden Star Was Identified GBDC Stock +24.76% Since The Golden Star Was Identified Unlock Golden Star List
RSI low/high Values: [ 20 - 80 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.

FAQ

What is the symbol for Ophthotech Corporation Stock and on which exchange is it traded?
The symbol for Ophthotech Corporation is OPHT and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Ophthotech Corporation Stock?
Ophthotech Corporation holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.

How to buy Ophthotech Corporation Stock?
Ophthotech Corporation Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Ophthotech Corporation Stock.

What's the current price of Ophthotech Corporation Stock?
As of the end of day on the 2022-08-17, the price of an Ophthotech Corporation (OPHT) share was $16.10.

What is the 52-week high and low for Ophthotech Corporation Stock?
The 52-week high for Ophthotech Corporation Stock is $19.32 and the 52-week low is $8.37.
Click to get the best stock tips daily for free!

About Ophthotech Corporation

Ophthotech Corporation, a biopharmaceutical company, develops novel therapeutics to treat diseases of the back of the eye. Its principal product candidate, Fovista, an anti-platelet derived growth factor, is in Phase III clinical development for use in combination with anti-vascular endothelial growth factor drugs for the treatment of wet age-related macular degeneration (AMD). The company is also developing Zimura, an inhibitor of complement fac... OPHT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT